Skip to main content
CivicGate

HR 1563
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

STOP Fentanyl and Xylazine Act

To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.

Introduced Feb 25, 2025

Latest action (Feb 25, 2025) Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Referred to
Energy and Commerce Committee Judiciary Committee
Policy area
Crime and Law Enforcement
Legislative subjects (2)
Criminal procedure and sentencingDrug trafficking and controlled substances

Summary

This bill amends the Controlled Substances Act to clarify that drug testing equipment designed to detect the presence of fentanyl or xylazine is not illegal under federal law. The bill specifies that the possession, sale, purchase, importation, exportation, or transportation of such testing equipment is not unlawful. This removes legal barriers to the distribution and use of fentanyl and xylazine testing equipment, allowing individuals to test substances for these drugs.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)
1 cosponsor

Money behind the sponsor

Top reported contributors to Jasmine Crockett’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.

  • DHR HEALTH $14,500
  • MILLER WEISBROD OLESKY $7,750
  • MATTHEWS SOUTHWEST $6,600
  • COINBASE $6,600
  • PIVOTAL VENTURES $6,600

Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Jasmine Crockett → · Outside spending →

Actions (2)
  1. Feb 25, 2025 Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · house
  2. Feb 25, 2025 Introduced in House

More bills on these subjects (8)

Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).

  • HR 9770 — Continuing Appropriations Act, 2027 (shares 2 subjects)
  • HR 1266 — Combating Illicit Xylazine Act (shares 2 subjects)
  • HR 5880 — Fight Illicit Pill Presses Act (shares 2 subjects)
  • HR 7148 — Consolidated Appropriations Act, 2026 (shares 2 subjects)
  • HR 7006 — Financial Services and General Government and National Security, Department of State, and Related Programs Appropriations Act, 2026 (shares 2 subjects)
  • S 2882 — Continuing Appropriations and Extensions and Other Matters Act, 2026 (shares 2 subjects)
  • HR 3838 — Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 (shares 2 subjects)
  • HR 5450 — Continuing Appropriations and Extensions and Other Matters Act, 2026 (shares 2 subjects)

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

  • S 545 — Combating Illicit Xylazine Act · Introduced Apr 15, 2026 · Cong. 119 74%
  • HR 1266 — Combating Illicit Xylazine Act · Introduced Jul 21, 2026 · Cong. 119 70%
  • HR 8005 — Stop Pills That Kill Act · Introduced Jul 15, 2026 · Cong. 119 69%
  • HR 1064 — Stopping Overdoses of Fentanyl Analogues Act · Introduced Feb 6, 2025 · Cong. 119 66%
  • S 331 — HALT Fentanyl Act · Became Law Jul 16, 2025 · Cong. 119 65%
  • HR 2964 — Fight Fentanyl Act · Introduced Apr 17, 2025 · Cong. 119 63%

Text versions (1)
  • Introduced in House · Feb 25, 2025

Only one text version is on file, so there’s no earlier version to compare against yet.

Full text

IN THE HOUSE OF REPRESENTATIVES

February 25, 2025

Ms. Crockett (for herself and Mr. Gooden) introduced the following bill; which was referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act” or the “STOP Fentanyl and Xylazine Act”.

SEC. 2. CLARIFICATION REGARDING THE TREATMENT OF EQUIPMENT THAT INDICATES THE PRESENCE OF FENTANYL OR XYLAZINE IN A COMPOUND.

Section 422 of the Controlled Substances Act (21 U.S.C. 863) is amended by adding at the end the following:

“(g) Clarification.—This section does not apply to the possession, sale, purchase, importation, exportation, or transportation of equipment for which the intended use is to indicate the presence of fentanyl or xylazine in a compound.”. <all>

Comments

Comments

Loading comments…